Characterization of a high-throughput screening assay for inhibitors of Elongation Factor P and ribosomal peptidyl transferase activity

被引:9
作者
Swaney, Steven
McCroskey, Mark
Shinabarger, Dean
Wang, Zhigang
Turner, Benjamin A.
Parker, Christian N.
机构
[1] Pfizer, Global Technol, Biol I, Kalamazoo, MI USA
[2] Pfizer, Global Enzymol & Kinet, Kalamazoo, MI USA
[3] Pfizer, Global HTS, Kalamazoo, MI USA
关键词
protein synthesis; Elongation Factor P; high-throughput screening;
D O I
10.1177/1087057106291634
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Elongation Factor P (EF-P) is an essential component of bacterial protein synthesis, enhancing the rate of translation by facilitating the addition of amino acids to the growing peptide chain. Using purified Staphylococcus aureus EF-P and a reconstituted Escherichia coli ribosomal system, an assay monitoring the addition of radiolabeled N-formyl methionine to biotinylated puromycin was developed. Reaction products were captured with streptavidin-coated scintillation proximity assay (SPA) beads and quantified by scintillation counting. Data from the assay Were used to create a kinetic model of the reaction scheme. In this model, EF-P binding to the ribosome essentially doubled the rate of the ribosomal peptidyl transferase reaction. As described here, EF-P bound to the ribosomes with an apparent K-a of 0.75 mu M, and the substrates N-fN4et-tRNA and biotinylated puromycin had apparent K(m)s of 19 mu M and 0.5 mu M, respectively. The assay was shown to be sensitive to a number of antibiotics known to target ribosomal peptide bond synthesis, such as chloramphenicol and puromycin, but not inhibitors that target other stages of protein synthesis, such as fusidic acid or thiostrepton.
引用
收藏
页码:736 / 742
页数:7
相关论文
共 11 条
[1]   Cloning of an EF-P homologue from Bacteroides fragilis that increases B-fragilis glutamine synthetase activity in Escherichia coli [J].
Abratt, VR ;
Mbewe, M ;
Woods, DR .
MOLECULAR AND GENERAL GENETICS, 1998, 258 (04) :363-372
[2]   The gene encoding the elongation factor P protein is essential for viability and is required for protein synthesis [J].
Aoki, H ;
Dekany, K ;
Adams, SL ;
Ganoza, MC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (51) :32254-32259
[3]   THE ARCHAEBACTERIAL HYPUSINE-CONTAINING PROTEIN - STRUCTURAL FEATURES SUGGEST COMMON ANCESTRY WITH EUKARYOTIC TRANSLATION INITIATION FACTOR-5A [J].
BARTIG, D ;
LEMKEMEIER, K ;
FRANK, J ;
LOTTSPEICH, F ;
KLINK, F .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1992, 204 (02) :751-758
[4]   PEPTIDE-BOND FORMATION STIMULATED BY PROTEIN-SYNTHESIS FACTOR EF-P DEPENDS ON THE AMINOACYL MOIETY OF THE ACCEPTOR [J].
GLICK, BR ;
CHLADEK, S ;
GANOZA, MC .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1979, 97 (01) :23-28
[5]  
GLICK BR, 1976, EUR J BIOCHEM, V71, P439
[6]   Program DYNAFIT for the analysis of enzyme kinetic data: Application to HIV proteinase [J].
Kuzmic, P .
ANALYTICAL BIOCHEMISTRY, 1996, 237 (02) :260-273
[7]  
Lajiness MS, 1997, PERSPECT DRUG DISCOV, V7-8, P65
[8]   ANTIBACTERIAL ACTION OF PRIMAQUINE - EFFECTS INVITRO ON POLYPEPTIDE-SYNTHESIS AND INVIVO ON RIBOSOMES AND RIBOSOMAL RIBONUCLEIC-ACID [J].
OLENICK, JG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1975, 8 (06) :754-756
[9]   SPARK - A novel method to monitor ribosomal peptidyl transferase activity [J].
Polacek, N ;
Swaney, S ;
Shinabarger, D ;
Mankin, AS .
BIOCHEMISTRY, 2002, 41 (39) :11602-11610
[10]   Mechanism of action of streptogramins and macrolides [J].
Vannuffel, P ;
Cocito, C .
DRUGS, 1996, 51 :20-30